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Ischemic renal injury is a formidable clinical problem,
the pathophysiology of which is incompletely understood.
As the Na/H exchanger-3 (NHE3) mediates the bulk of apical
sodium transport and a significant fraction of oxygen
consumption in the proximal tubule, we examined
mechanisms by which ischemia–reperfusion affects the
expression of NHE3. Ischemia–reperfusion dramatically
decreased NHE3 protein and mRNA (immunohistochemistry,
immunoblot, and RNA blot) in rat kidney cortex and medulla.
The decrease in NHE3 protein was uniform throughout all
tubules, including those appearing morphologically intact.
In the kidney cortex, a decrease in NHE3 surface protein
preceded that of NHE3 total protein and mRNA. Kidney
homogenates from rats exposed to mild renal ischemia-
reduced cell surface NHE3 protein expression in opossum
kidney cells in vitro, whereas homogenates from animals with
moderate-to-severe ischemia reduced both total NHE3
protein and mRNA. The decrease in total NHE3 protein was
dependent on the proteasomal degradation associated with
NHE3 ubiquitylation measured by coimmunoprecipitation.
The transferable factor(s) from the ischemic homogenate
that reduce NHE3 expression were found to be heat sensitive
and to be associated with a lipid-enriched fraction, and did
not include regulatory RNAs. Thus, transferable factor(s)
mediate the ischemia–reperfusion injury-induced decrease
in NHE3 of the kidney.
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Acute kidney injury (AKI) from ischemia is a common
syndrome in clinical nephrology.1,2 Despite advances in
multiple fronts in overall clinical care, the morbidity and
mortality of this syndrome remain staggeringly high.1–4 Until
recently, therapeutic options consisted of largely supportive
measures,4,5 and numerous therapies designed to alter the
course of the illness with proven efficacy in animal models
have encountered rather disappointing results in subsequent
human trials.6–8 On a positive note, considerable efforts are
being devoted to understanding this syndrome and some
recent interventional agents may appear more promising.8,9
A thorough understanding of the pathophysiology of acute
ischemic renal injury is critical for further advances in the
treatment of this disorder.
The effect of ischemia–reperfusion (IR) on Na/H exchan-
ger-3 (NHE3), the principal renal apical membrane Naþ
transporter, is the focus of the present study. NHE3 is a
member of a mammalian gene family of transmembrane
proteins that facilitate electroneutral exchange of Naþ for
Hþ . NHE3 is expressed in the apical membrane of the
mammalian proximal convoluted tubule and thick ascending
limb.10 In the proximal tubule, NHE3 is responsible for 50%
and 70% of volume and bicarbonate absorption, respec-
tively.11,12 In the thick ascending limb, NHE3 mediates most
of the bicarbonate absorption,13 and its role in NaCl
absorption is more controversial. The functional role of
NHE3 in maintenance of systemic volume and acid–base
homeostasis is evident from the massively reduced proximal
absorption, systemic hypotension, and metabolic acidosis
seen in NHE3-null mice, despite distal compensation.14–16
Previous studies have described a reduction in renal NHE3
transcript and protein after IR injury.17–19 It was postulated
that reduction of NHE3 expression can potentially explain
the clinical findings of salt wasting and disordered acidifica-
tion, which is occasionally encountered in AKI.20 The
mechanisms by which NHE3 activity and expression are
regulated are manifold, many of which are not well under-
stood. In other physiological and pathophysiological models,
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NHE3 is regulated at the levels of protein phosphorylation,
protein–protein interaction, trafficking, translation, and
transcription.21 The current study shows that, after IR,
NHE3 expression is reduced via changes in NHE3 surface,
total protein, and transcript abundance because of transfer-
able factor(s) present in ischemic renal tissue. These factor(s)
are heat sensitive, may have a lipid component, or may
associate with lipid fractions, but are not regulatory RNAs.
These factor(s) induce destabilization of NHE3 protein by
means of proteasomal degradation of ubiquitylated NHE3
and will reduce NHE3 transcript.
RESULTS
Time course of NHE3 protein and transcript
IR leads to severe reduction in NHE3 protein in both the
cortex and medulla. In the renal cortex (Figure 1a and b),
NHE3 reduction is evident by 16 h and is maximal at 1 day.
Recovery begins at 7 days and is complete by 10–14 days
(Figure 1b). The trend is similar for both apical and total
membranes; however, changes in apical membrane NHE3
are more prominent at 16 h, compared with that of NHE3
total membrane. Figure 2a and b shows the corresponding
results in total membranes from the medulla. The reduction
is evident by 16 h, maximal by 3 days, and recovery is
complete by 10–14 days. Decrease in NHE3 protein is
associated with a decrease in NHE3 transcript in both the
cortex and medulla (Figures 3 and 4). Reduction in NHE3
transcript in the cortex is evident by 16 h and reaches its
maximum on day 1. Recovery begins at 3 days and is
complete by 10–14 days. In the medulla, reduction in
NHE3 transcript is significant by 16 h, maximal by 1 day,
and recovery is complete by 10–14 days. Decreases in
NHE3 protein (in particular, in the NHE3 apical membrane
of the renal cortex) precede that of and are more severe
than decreases in NHE3 transcript early post-ischemia.
This suggests that there are translational and/or post-
translational events involved in the reduction of NHE3
protein after injury from IR. Furthermore, reduction in
NHE3 protein is dramatic with loss of up to 80% of total
cellular NHE3 on day 1. Considering that this model
usually leads to only patchy areas of tubular necrosis, loss
of NHE3 protein must also occur in morphologically normal
tubules.
Immunohistochemistry of NHE3 protein
As expected, IR resulted in patchy areas of tubular necrosis.
In contrast, loss of NHE3 expression was quite global in
distribution (Figures 5 and 6). We counterstained the
sections with Evans blue to visualize the apical brush border.
Figure 6a and b shows a representative tubule where the
apical brush border is intact and yet is largely devoid of
NHE3 protein. In sham-operated animals, NHE3 protein
expression was robust at the brush border (Figure 6c), as
expected.10 These findings indicate that decrease in NHE3
expression is not a result of destruction of the apical brush-
border membrane.
Effect of ischemic extract on NHE3 in opossum kidney cells
Considering that disappearance of NHE3 protein extends far
beyond morphological tubular lesions, we postulated that
diffusible factor(s) might be responsible for this effect.
We used a proximal tubule-like cell that expresses native
NHE3, opossum kidney cells (OK cells), to test the hypothesis
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Figure 1 | Immunoblot of Na/H exchanger-3 (NHE3) antigen in
apical and total membranes from the renal cortex. Rats were
subjected to either 40min of bilateral renal artery cross-clamp
(ischemia) or sham manipulation (sham). At indicated times, the
animals were killed and total and apical membrane vesicles were
prepared from the renal cortex and probed for NHE3 antigen by
immunoblot. (a) Representative immunoblot. (b) Summary of all
data collected at 16 h and 1, 3, 7, 10, and 14 days (d) after the
ischemia or sham manipulation. NHE3 antigen in apical
membrane (ischemia as a percentage of sham, and relative
statistical determination of significance): 16 h 41%, Po0.01; 1 day
9%, Po0.01; 3 days 20%, Po0.01; 7 days 26%, Po0.01; 10 days
81% P¼ 0.07; 14 days 94%, P¼ 0.5. NHE3 antigen in the total
cortex (ischemia as a percentage of sham, and relative statistical
determination of significance): 16 h 59%, Po0.05; 1 day 22%,
Po0.01; 3 days 17%, Po0.01; 7 days 19%, Po0.01; 10 days 74%,
Po0.05; 14 days 91%, P¼ 0.7. Each data point represents the
mean and s.e. from 3–5 independent animals. Asterisks indicate
statistically significant difference between the sham and ischemia
groups (Po0.05, unpaired t-test for each time point).
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in vitro. Homogenates from ischemic kidneys rapidly induced
loss of NHE3 total protein in OK cells in a dose- and time-
dependent manner, whereas renal homogenates from sham-
operated animals had no effect on NHE3 protein (Figure 7a
and b). Interestingly, reduction of NHE3 protein is associated
with a reduction in the NHE3 transcript and depends on the
duration of ischemia and on the severity of renal dysfunction
(Figure 7c). We measured NHE3 surface, total protein,
and transcript expression in OK cells after addition of
ischemic renal homogenates obtained after varying dura-
tions (30–60 min) of ischemia. Homogenates from mild
ischemia (plasma creatinine (PCr)¼ 0.9–2.1 mg/ml 48 h post
IR) induced a decrease of NHE3 surface protein but not of
total protein and transcript expression (Figure 7c). Homog-
enates obtained from moderate (PCr¼ 2.2–3.0 mg/ml) and
severe (PCr43.0 mg/ml) ischemia decreased NHE3 surface
and total protein and transcript expression (Figure 7c).
Generally, 30, 40, or 60 min of ischemia leads to mild,
moderate, or severe ischemia, respectively, although this is
not universally true because of some animal-to-animal
variations. This is why we chose PCr values to distinguish
between severities of ischemia.
Variation in degrees of renal damage affects NHE3
regulation differently in vitro. We retrospectively looked
at whole-animal data and found that degrees of ischemia
also affect NHE3 regulation differentially in vivo (Supple-
mentary Table S1 online).
Next, we evaluated the mechanisms that decrease NHE3
total protein in vitro. The rapidity of the effect of the
ischemic extract on NHE3 protein suggests that NHE3 is
targeted for degradation. Inhibition of the lysosomal
pathway had little effect on ischemic homogenate-induced
decrease in NHE3 protein in OK cells (Figure 8a and b). In
contrast, inhibition of the proteasomal pathway abrogated
the decrease in NHE3 expression in response to ischemic
homogenates over the 4 h period (Figure 8a and b).
Ubiquitylation is a prerequisite for identifying proteins
for proteasomal degradation. Figure 8c shows that NHE3
is acutely ubiquitinated upon exposure to ischemic renal
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Figure 2 | Immunoblot of Na/H exchanger-3 (NHE3) antigen in
total membranes from the renal medulla. At the indicated
times post ischemia or sham manipulation, the animals were
killed and membranes were prepared from the renal medulla and
probed for NHE3 antigen by immunoblot. (a) Representative
immunoblot. (b) Summary of all data collected at 16 h and 1, 3, 7,
10, and 14 days (d) after the ischemia or sham manipulation. NHE3
antigen (ischemia as a percentage of sham, and significance): 16 h
26%, Po0.01; 1 day 13%, Po0.01; 3 days 8%, Po0.01; 7 days 9%,
Po0.01; 10 days 85% P¼ 0.05; 14 days 88%, P¼ 0.7. Each data
point represents the mean and s.e. from 3–5 independent animals.
Asterisks indicate statistically significant difference between
the sham and ischemia groups (Po0.05, unpaired t-test for each
time point).
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Figure 3 |RNA blot of Na/H exchanger-3 (NHE3) transcript in
the renal cortex. At indicated times post ischemia or sham
manipulation, the animals were killed and total RNA was prepared
from the renal cortex and probed for NHE3 transcript by RNA blot.
(a) Representative RNA blot. (b) Summary of all data collected
at 16 h and 1, 3, 7, 10, and 14 days (d) after the ischemia
or sham manipulation. NHE3 transcript (ischemia as a percentage
of sham, and significance): 16 h 87.5%, P¼ 0.10; 1 day 25%,
Po0.001; 10 days 75%, Po0.01; 14 days 87%, P¼ 0.16.
Each data point represents the mean and s.e. from 3–5
independent animals. Asterisks indicate statistically significant
difference between the sham and ischemia groups
(Po0.05, unpaired t-test).
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homogenates. In concert, these results support the notion
that factor(s) in the ischemic tissue target NHE3 for
destruction through ligation with ubiquitin and degrada
tion in the proteasome.
Characterization of transferable factor(s) in the ischemic
renal homogenate
We next initiated the characterization of transferable
factor(s) in the ischemic homogenate, which is a formidable
task because the effect on NHE3 could be, and likely is,
mediated by a combination of factors of different natures.
Heating the homogenates to 95 1C significantly reversed the
reduction in NHE3 total protein induced by the ischemic
renal homogenate (Figure 9a and b). This reversal could be
because of heat denaturation of protein structure, suggesting
that the transferable factor(s) may be proteins or protein-
bound molecules that are destabilized by protein dena-
turation. We next evaluated whether the transferable factor(s)
are lipids or lipid associated. Removal of the lipid fraction
from the ischemic renal homogenate significantly blunted the
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Figure 4 |RNA blot of Na/H exchanger-3 (NHE3) transcript in
the renal medulla. At indicated times post ischemia or sham
manipulation, the animals were killed and total RNA was prepared
from renal medulla and probed for NHE3 transcript by RNA blot.
(a) Representative RNA blot. (b) Summary of all data collected at
16 h and 1, 3, 7, 10, and 14 days (d) after the experimental or sham
manipulation. NHE3 transcript (ischemia as a percentage of sham,
significance): 16 h 70%, Po0.001; 1 day 5%, Po0.001; 10 days
90%, P¼ 0.1; 14 days 97%, P¼ 0.8. Each data point represents the
mean and s.e. from 3–5 independent animals. Asterisks indicate
statistically significant difference between the sham and ischemia
groups (Po0.05, unpaired t-test).
Sham Ischemia
Figure 5 | Immunohistochemistry of Na/H exchanger-3 (NHE3)
antigen in the renal cortex. Two days after either ischemia or
sham manipulation, kidneys were perfusion-fixed and stained for
NHE3 expression (NHE3 antibody #1568). Four independent
animals from each group showed similar findings.
Figure 6 | Immunohistochemistry of Na/H exchanger-3 (NHE3)
antigen counterstained with Evans Blue in the renal cortex.
Two days after either ischemia or sham manipulation, kidneys
were perfusion-fixed and stained for NHE3 expression. NHE3
expression after ischemia manipulation visualized by Fluorescein
isothiocyanate-conjugated secondary antiserum (green) can be
seen against the background of brush-border staining by Evans
Blue (blue). (a) Low power showing three tubules. (b) High power
of one tubule. Arrowheads indicate the brush border. (c) A tubule
from a sham-operated animal for comparison. Four independent
animals from each group showed similar findings.
Kidney International (2011) 80, 822–831 825
F Di Sole et al.: Renal ischemia and regulation of NHE3 protein o r ig ina l a r t i c l e
reduction of NHE3 total protein by the ischemic renal
extract. Lipid-enriched kidney homogenates from IR rats
induced a significant decrease in NHE3 protein compared
with lipid-enriched extract from sham-operated rats. Finally,
we tested whether components of the transferable factor(s)
may be small protein-bound RNA molecules. Large RNAs
will not survive endogenous ribonuclease (RNAse) in our
preparation, but small RNA molecules (for example, micro-
RNAs) associated with binding proteins will be relatively
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Figure 7 | Effect of kidney homogenates on Na/H exchanger-3
(NHE3) expression in opossum kidney (OK) cells: time-, dose-,
and kidney damage-dependence. Two days after either
ischemia or sham manipulation, the animals were
nephrectomized and kidney homogenates were applied to
confluent quiescent OK cells in culture for 4 h. (a) A representative
blot showing a dose response. (b) Summary of all data for dose-
and time-dependence. (c) Surface and total NHE3 protein and
NHE3 transcript were measured after 1mg/ml of kidney
homogenates was applied to OK cells. Data were arbitrarily
divided into mild (plasma creatinine (PCr)¼ 0.9–2.1mg/ml, 48 h
post IR), moderate (PCr¼ 2.2–3.0mg/ml, 48 h post IR), and severe
(PCr43.0mg/ml, 48 h post IR) ischemia. PCr from sham animals
was 0.4–0.5mg/ml. Typical blots and the summarized data are
shown. Data points are expressed as mean and s.e. from 3–4
independent experiments. Asterisks denote statistically significant
difference between cells treated with ischemic and those treated
with sham homogenate (Po0.05, unpaired t-test). IR, ischemia–
reperfusion.
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Figure 8 | Effect of kidney homogenate on Na/H exchanger-3
(NHE3) expression in opossum kidney (OK) cells: inhibition of
lysosomal versus proteasomal pathways, and NHE3
ubiquitylation. Two days after either ischemia or sham
manipulation, animals were nephrectomized and 0.1mg/ml of
kidney homogenates was applied to confluent quiescent OK cells
for 4 h, either alone or in combination with inhibitors of lysosomal
(leupeptin 0.5mg/ml) or proteasomal pathways (lactacystin
10mmol/l). (a) Representative experiment. (b) Summary of all data.
Data points are expressed as mean and s.e. from 3–4 independent
experiments. Asterisks denote statistically significant difference
between cells treated with ischemic homogenate and those
treated with sham homogenate (Po0.05, unpaired t-test).
(c) OK cells were transiently transfected with HA-ubiquitin
(HA-Ub). Extracts from ischemic or sham-treated kidneys were
added to OK cells, as described above, in the presence of
10mmol/l lactacystin to arrest endogenous proteasomal
degradation of ubiquitinated NHE3. HA-ubiquitin was then
immunoprecipitated with anti-HA antibody and immunoblotted
with polyclonal anti-NHE3 (#5683) antibody to detect NHE3
ubiquitylation. One representative experiment is shown on the
left and summary of all data is shown on the right. Data points are
expressed as mean and s.e. from 3–4 independent experiments.
Asterisks denote statistically significant difference between cells
treated with ischemic homogenate and those treated with sham
homogenate (Po0.05, unpaired t-test).
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resistant. Renal cortical homogenates were subjected to
proteinase to remove RNA-binding proteins, followed by
RNAse treatment. Pretreatment with proteinase K is an
effective method of exposing small protein-bound RNA
molecules to degradation.22 Heating the homogenates to
95 1C significantly blunted the inhibitory effect of ischemic
homogenates on OK cell NHE3 abundance, and no further
change was detectable after proteinase and RNAse treatment,
which rules out regulatory RNAs as candidates (Figure 9c).
DISCUSSION
Prominent among the functional effects induced by IR
injury is reduced Naþ and water tubular reabsorption. The
abundance of several major Naþ transporters, including
NHE3, is drastically reduced after acute IR in rats.17–19 It was
postulated that severe suppression of NHE3 represents, at
least in part, the molecular basis for the natriuresis, acidosis,
and volume depletion observed after IR injury.17,19 In this
model, downregulation of NHE3 constituted a pathophysio-
logical event that could potentially worsen the clinical
syndrome. However, in most clinical settings, salt wasting is
actually not a usual encounter in AKI. An alternative, but
not necessarily mutually exclusive, view of downregulation of
NHE3 in this scenario is that this is not a consequence of
damage to the proximal tubule but is rather an adaptive
defense mechanism. This notion frames the whole finding in
a different light. First is conservation of energy in the
proximal tubule as proposed by Blantz et al.23 As active Naþ
transport constitutes the bulk of ATP consumption24 in this
largely aerobic nephron segment,25,26 a rapid reduction in
Naþ transport by downregulating the principal apical Naþ
entry step achieves that purpose rapidly. Second is conserva-
tion of isotonic extracellular fluid as proposed by Thurau
et al.27 If tubular transport is reduced, it is critical that
glomerular filtration be curtailed to prevent massive volume
loss. Increased distal solute delivery to the macula densa can
be partially responsible for reduction of the glomerular
filtration rate in acute tubular necrosis.28 Loss of NHE3
in NHE3/ animals results in severe reduction of glomerular
filtration rate through activated tubulo-glomerular feedback,
which is one of the mechanisms why these animals do not
succumb to circulatory collapse.15 Third is the model that
reduction in proximal tubule apical Naþ entry may in fact be
cyto-protective to cells, as low cell Naþ accelerates Ca2þ
efflux and ameliorates Ca2þ -mediated cell injury.29 From
these viewpoints, downregulation of NHE3 becomes a vital
part, rather than an undesirable consequence, of the tubular
response to IR injury. Understanding how NHE3 is down-
regulated in this setting is critical to understanding the renal
response to IR. The present study focused on studying some
of the molecular mechanisms by which IR regulates NHE3
expression.
First, we found that IR induces a drastic reduction of
NHE3 protein and transcript in the rat kidney. Our data are
comparable to previously reported findings of drastic
reduction of renal NHE3 in IR.17–19 However, urinary
NHE3 protein abundance was found to be increased in
patients with acute tubular necrosis compared with normal
subjects.30 In the setting of tubular necrosis, it is unclear
whether antigen in urinary exosomes actually mirrors renal
levels on the basis of constitutive shedding or is more a
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Figure 9 |Characterization of extractable tissue factor(s).
Opossum kidney (OK) cells were incubated with 1mg/ml of
kidney homogenate from ischemic or sham-operated rats (for 4 h)
and total Na/H exchanger-3 (NHE3) protein abundance was
quantified by immunoblot. Data points are expressed as
mean±s.e. from 3–4 independent experiments. Asterisks denote
statistically significant difference between cells treated with
ischemic and those treated with sham homogenate (Po0.05,
unpaired t-test). #Po0.05 analysis of variance (ANOVA), OK cells
treated with heated (or lipid deprived) kidney homogenates
compared with OK cells treated with control kidney
homogenates. $Po0.05 ANOVA, OK cells treated with lipid-
enriched renal cortical homogenates compared with OK cells
treated with lipid-deprived (post-lipid) kidney homogenates.
(a) Representative experiment and (b) summary of all data of renal
extract heated (95 1C for 10min), lipid enriched (lipid enriched),
or lipid deprived (post-lipid). (c) Representative experiment and
summary of all data of heated, proteinase K and ribonuclease
(RNAse) treatment of kidney homogenates. þ : addition of
indicated treatment.
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reflection of discharge through necrosis. Both NHE3 protein
and transcript in the kidney reverse back to control levels
after about 7–10 days, which is congruent with the recovery
of PCr in this rat model of acute IR.31 Furthermore, we found
that decreased NHE3 expression starts in the apical
membrane, followed by total protein and then transcript.
This sequence suggests differential mechanisms that operate
to downregulate NHE3-mediated transport.
Second, we determined that reduction in NHE3 expres-
sion is not necessarily associated with tubular necrosis or loss
of apical membrane structure but can be globally distributed.
These observations suggest that inhibition of NHE3 might
not be a consequence of proximal tubule damage but is rather
a generalized adaptive response mechanism to cope with low
ATP supply. In support of this hypothesis, pretreatment with
the NHE inhibitor EIPA (5-(N-ethyl-N-isopropyl) amiloride)
attenuated Naþ fractional excretion and renal endothelin-1
released in response to IR injury.32 Pharmacological in-
hibition of NHE3 with S3226 decreased serum creatinine after
IR and improved acute renal failure.33 Systemic administra-
tion of another specific inhibitor of NHE3 also improves
tubular function in acute renal failure and provides protection
from acute rejection in renal transplant in rats.34 The finding
that changes in NHE3 function are not exclusively restricted
to damaged tubules but are globally distributed may be key to
understanding the pathophysiology of AKI, considering that
tubular necrosis is extremely patchy in AKI in humans.35
Third, we found an abrupt decrease in NHE3 in OK
cells never exposed to hypoxia but treated with homog-
enates from ischemic animals. Release of diffusible factor(s)
in IR injury may have a significant role in the reduction
of NHE3 expression. Indeed, growing evidence indicates
that inflammatory response has a major role in IR injury.36
Inflammatory cascades initiated by endothelial dysfunction
can be augmented by the ischemic proximal tubule.
These include proinflammatory (for example, tumor necrosis
factor-a, interleukin (IL)-6, IL-1b, and transforming growth
factor-b) and chemotactic cytokines (for example, monocyte
chemoattractant protein-1, IL-8, RANTES).37 IL-1b and
tumor necrosis factor-a, especially in combination, exten-
sively downregulate the expression of several Naþ trans-
porters, including NHE3.38 In contrast, a-MSH, an
anti-inflammatory agent that inhibits neutrophil migration
and production of neutrophil chemokines,39 reversed the
reduced abundance of Naþ transporters (for example,
NHE3) and the marked increase in FENa induced by IR
injury.40 These data favor the hypothesis that inhibition of
NHE3 constitutes a pathophysiological event secondary
to damage in IR injury. Alternatively, one can also view
that amelioration of injury necessitates less protection by
downregulation of NHE3.
Intracellular mediators also allow cells to respond and
adapt to low oxygen tension. Hypoxia-inducible factors
facilitate both oxygen delivery and adaptation to oxygen
deprivation by regulating several cellular mechanisms such as
intracellular pH through induction of NHE1 expression.41,42
Our findings support the view that diffusible factor(s)
released or activated in the tubular epithelium are heat-labile
and comprised probably lipid and protein or protein in
lipid-enriched domains, but not regulatory RNA compo-
nents. Changes in lipid content and microRNA expression,
which is an important regulator of gene expression,43 have
also been associated with kidney dysfunction in AKI.44,45
Fourth, we proposed that these diffusible factor(s) released
during IR injury affect NHE3 surface, total protein, and
transcript expression likely through different mechanisms.
Concordant changes in NHE3 protein and transcript have
been previously described for other regulators of
NHE3.21,46,47 Acid incubation, for example, increases NHE3
membrane insertion, total protein, and transcript with
different kinetics.48–51 Mildly ischemic extracts added to
OK cells clearly reduce only surface NHE3 protein. This is
compatible with the early time point (16 h post IR), in which
the magnitude of decrease in surface NHE3 exceeds the
decrease in total NHE3, and with milder ischemia, in which
the decrease in surface NHE3 is greater than total cellular
NHE3 (Supplementary Table S1 online). In extracts from
more severe renal damage, total cellular NHE3 protein and
NHE3 transcript are both decreased, although the reduced
transcript may or may not contribute to reduced protein.
The proteasomal and lysosomal pathways are the two major
proteolytic systems described in eukaryotic cells.52,53 The rapid
reduction of NHE3 antigen is largely mediated by NHE3
degradation through the ubiquitin-proteasome proteolytic
system. Ubiquitin has a major role in protein degradation as
it serves as a tag for recognition of proteins by the proteolytic
pathway.54–56 There are multiple examples of transport proteins
being degraded by the ubiquitin–proteasome system,54,57–61
including NHE1.62 We did not determine whether a decrease
in NHE3 transcript is mediated by the same factors(s) or
mechanisms that induce NHE3 protein degradation.
In summary, we found that IR injury induces reduction in
NHE3 surface and total protein and in NHE3 transcript.
Recruitment of each of these mechanisms may occur through
different pathways and may vary with the degree of kidney
damage. We propose that downregulation of NHE3 at diverse
levels may initiate a rapid way of conservation of energy and
protect the cell; however, this study does not prove this
conjecture. Reduction of NHE3 protein and transcript was
induced by addition of ischemic homogenates to OK cells,
suggesting that release of diffusible factor(s), which are likely
proteins or proteolipid complexes, has a significant role in
the inhibition of NHE3.
MATERIALS AND METHODS
Animal model
IR injury was induced in rats using protocols approved by the
Institutional Animal Care and Use Committee. Sprague–Dawley
rats (200–250 g, Harlan, Indianapolis, IN) were anesthetized
(100 mg/kg ketamine, 10 mg/kg xylazine, and 1 mg/kg aceproma-
zine; intramuscular) and placed on a heating table (39 1C) to
maintain constant body temperature. Through a midline incision,
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bilateral cross-clamps were applied across the dissected renal artery
for a designated period of time. Sham-operated animals were
subjected to identical treatment, except that no cross-clamps were
applied. After releasing the cross-clamps, kidneys were visually
inspected to ensure restoration of blood flow, and 1 ml of
prewarmed (37 1C) saline was instilled into the abdominal cavity
and the abdomen was closed in two layers. The animals were placed
in a 29 1C recovery and observation incubator overnight before
being returned to their regular facilities.
Assays for NHE3 protein and transcript in rat kidney
homogenates
NHE3 protein was measured in total membranes from the renal
cortex and medulla and in apical membranes from the cortex. Kidneys
were cooled and rinsed in ice-cold PBS. One kidney was harvested for
protein, whereas the contralateral kidney was used for RNA
preparation. The cortex and medulla were manually dissected from
decapsulated kidneys. For protein preparation, tissue was homog-
enized (Brinkman Polytron, Beckman, Fullerton, CA) in membrane
buffer (in mmol/l: 150 NaCl, 50 Tris-HCl pH 8.0, 5 EDTA; in mg/ml:
100 PMSF, 2 leupeptin, 2 aprotinin, 2 pepstatin A). Debris was
pelleted by centrifugation (5000 g, 5 min, 4 1C) and total membranes
were separated from cytosol (55,000 g, 40 min, 4 1C), resuspended in
dye-free SDS loading buffer (5 mmol/l Tris-HCl, pH 6.8, 1% SDS,
10% glycol, 1% b-mercaptoethanol, and 0.004% bomophenolblue),
and protein content was quantified by the colorimetric assay of
Bradford (Bio-Rad, Hercules, CA). The remainder of the cortical
homogenate was used to prepare renal cortical brush-border
membrane vesicles by Mg2þ aggregation.49 Total and apical
membranes (40mg and 10mg, respectively) were fractionated by
SDS-PAGE. NHE3 protein was detected by primary antisera (1:1000
dilution) #1568,10 followed by horse-radish peroxidase-conjugated
secondary antisera (Amersham Biosciences, Piscataway, NJ), and
quantified by densitometry. For RNA studies, tissue samples were
homogenized in guanidium thiocyanate solution (4 mol/l guanidium
thiocyanate, 0.1 mol/l b-mercaptoethanol, 0.025 mol/l Na3Citrate pH
7.0, 0.5% (w:v) N-lauroylsarcosine). RNA was extracted using phenol/
chloroform, ethanol precipitated, size fractionated with formaldehyde
gel electrophoresis, transferred to a nylon membrane, and hybridized
with a 32P-labeled 1.2 kbp PstI fragment of the rat NHE3 cDNA.
NHE3 RNA signal was detected by autoradiography and normalized
to 18S rRNA as previously described.51
Immunohistochemistry
Immunohistochemistry was performed at 48 h after either cross-
clamp or sham, as previously described.10 For NHE3 staining,
sections were preincubated for 5 min at room temperature with 3%
milk powder in PBS containing 0.05% Triton and overlaid overnight
at 4 1C with an NHE3 antibody (#1568) diluted 1:500. Sections were
rinsed three times with Tris-buffered saline before incubation (4 1C,
1 h) with secondary swine anti-rabbit Fluorescein isothiocyanate-
conjugated IgG (Dakopatts, Glostrup, Denmark). Slides were
counterstained with 3% aqueous Evans Blue dye and treated with
2.5% 1,4-diazabicyclo-(2.2.2)octane (Sigma, St Louis, MO) as a
fading retardant. Sections were imaged with a laser scanning
confocal microscope (Zeiss LSM 410, Zeiss, Jena, Germany).
Cell culture studies
OK cells were maintained as previously described.63,64 Confluent
monolayers were rendered quiescent by serum removal for 48 h
before experimentation. Renal cortical homogenates were prepared
from kidneys 48 h post either IR or sham operation. Varying
amounts of the homogenate were added to postconfluent OK cells.
At indicated times, cells were sonicated in membrane buffer and
membrane fractions were pelleted (109,000 g, 25 min, 4 1C).
A volume of 20mg of total OK cell membrane protein was immuno-
blotted with anti-OK NHE3 antiserum (1:1000 dilution) #5683.65
Parallel experiments were performed using inhibitors of lysosomal
(leupeptin, 0.5mg/ml) or proteasomal (lactacystin, 10mmol/l) path-
ways applied simultaneously with the renal homogenates. To
examine the effect of ischemic extract on NHE3 ubiquitylation, we
measured ubiquitylation by epitope-tagged ubiquitin because
different commercial anti-ubiquitin antibodies failed to generate
reproducible and reliable data in OK cells. OK cells were transfected
with hemagglutinin (HA)-tagged ubiquitin (HA-Ub), which was
provided by Dr Bohmann (University of Rochester, Rochester, NY).
Efficiency of transfection was about 70–80% by staining cells with
anti-HA (not shown). Extracts from ischemic- or sham-operated
animals were added for 4 h in the presence of 10mmol/l lactacystin to
arrest endogenous proteasomal degradation of ubiquitinated NHE3.
Cells were then lysed in buffer (in mmol/l: 150 NaCl, 50 Tris-HCl,
pH 8, 5 EDTA, 1 EGTA, 1% Triton X-100; in mg/ml: 100 PMSF, 2
leupeptin, 2 aprotinin, 2 pepstatin A)63 supplemented with 2 mmol/l
ubiquitin-aldehyde to inhibit in vitro ubiquitin cleavage. Ubiquitin
was immunoprecipitated with anti-HA and immunoblotted with
anti-NHE3 antibody to detect NHE3 ubiquitination.
A volume of 1 mg/ml of renal cortical homogenates from post-IR
or -sham operation was added to OK cells for 4 h for characteriza-
tion of transferable factor(s). To examine the heat stability of the
transferable factor(s), homogenates were heated for 10 min at 95 1C.
Denatured proteins were removed by centrifugation (20,000 g,
10 min, 4 1C) and cleared supernatant was added to OK cells.66
For proteinase K and RNAse treatment, the homogenates were
incubated with 100 mg/ml Proteinase K (Promega, Madison, WI) for
90 min at 37 1C, followed by Proteinase K inactivation at 95 1C for
10 min. Next, homogenates were incubated with 50 mg/ml of RNAse
mix from bovine pancreas (Roche Applied Science, Indianapolis,
IN) for 60 min at 37 1C, heated at 95 1C for 10 min, cooled to 37 1C,
and added to OK cells. Control homogenates without proteinase or
RNAse treatment were subjected to the same heating and cooling
steps. To examine whether the transferable factor(s) are enriched in
a lipid fraction, homogenates were centrifuged (40,000 g, 30 min,
4 1C), resulting in a sedimented membrane pellet, cytosolic fraction,
and floating lipid fraction. Floating lipids were separated from the
cytosolic fraction.67 The cytosolic fraction was filtered to remove
residual lipids.68 Collected floating lipids and filtered cytosolic
fractions were added separately to OK cells.
Quantification of surface NHE3 antigen by biotinylation and of
NHE3 transcript by quantitative real-time PCR was performed for
OK cells incubated with 1 mg/ml of homogenate for 4 h as
previously described.63,64,69,70 RNA isolation was carried out using
an RNeasy Mini Kit (QIAGEN, Valencia, CA) and reverse
transcription was carried out using the ThermoScript RT-PCR
system (Invitrogen, Carlsbad, CA). In the summary of data of total
NHE3 antigen, the antigen signal was normalized to b-actin mouse
monoclonal antibody (Sigma).
Statistical analyses
Results are presented as mean±s.e. Quantitative differences between
control and test conditions were assessed statistically by Student’s
t-test and analysis of variance. A probability (P) o0.05 was
considered statistically significant.
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